首页> 外文期刊>Journal of Psychiatry and Brain Science >Genetic Risk of Psychosis in Relation to Cannabis Use: Findings from Polygenic Risk Score Approaches
【24h】

Genetic Risk of Psychosis in Relation to Cannabis Use: Findings from Polygenic Risk Score Approaches

机译:关于大麻的心理学遗传风险使用:来自多基因风险评分方法的发现

获取原文
           

摘要

A psychotic disorder is a multifactorial phenomenon in which not only environmental influences but also genetic factors play an important role. Evidence indicates that psychotic disorders are characterized by a complex mode of inheritance with high polygenicity, in which a large number of common genetic variants with small effects are relevant. One way to measure this polygenic risk is the calculation of polygenic risk scores (PRS). These reflect the complex multifactorial interaction of coding and regulatory DNA variants in the development of mental illness. It is known that the use of cannabis in patients with schizophrenia (SCZ) is much higher than in the general population. Although an exact clinical prognosis based on PRS is not possible at the present, the results found by PRS investigations so far are quite promising. Initial results suggest that people with SCZ and an increased polygenic risk of schizophrenia are more likely to use cannabis. According to these results, the connection between mental illnesses and cannabis use could therefore not simply be seen as an environmental risk, but rather explained as a gene-environment correlation.
机译:精神病障碍是一种多因素现象,不仅环境影响,而且遗传因素也发挥着重要作用。证据表明,精神障碍的特征在于具有高多种性的复杂遗传模式,其中大量具有小效果的常见遗传变异是相关的。测量这种多基因风险的一种方法是计算多基因风险评分(PRS)。这些反映了编码和调节DNA变异在精神疾病发展中的复杂多因素相互作用。众所周知,在精神分裂症(SCZ)患者中使用大麻的使用远高于一般人群。虽然目前不可能基于PRS的确切临床预后,但PRS调查发现的结果是非常有前途的。初步结果表明,具有SCZ的人和精神分裂症的增加的多基因风险更可能使用大麻。根据这些结果,精神疾病和大麻使用之间的联系不能简单地被视为环境风险,而是作为基因环境相关性解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号